{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:46:38Z","timestamp":1793295998748,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0532-4","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T11:57:17Z","timestamp":1453982237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Paraproteinemic neuropathy: a practical review"],"prefix":"10.1186","volume":"16","author":[{"given":"Richard A.","family":"Rison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said R.","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"issue":"11","key":"532_CR1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1468-1331.2011.03380.x","volume":"18","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA. Neuropathy and paraproteins: review of a complex association. Eur J Neurol. 2011;18(11):1291\u20138. doi: 10.1111\/j.1468-1331.2011.03380.x .","journal-title":"Eur J Neurol"},{"issue":"9","key":"532_CR2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1080\/10428190903111922","volume":"50","author":"SA Zivkovic","year":"2009","unstructured":"Zivkovic SA, Lacomis D, Lentzsch S. Paraproteinemic neuropathy. Leuk Lymphoma. 2009;50(9):1422\u201333. doi: 10.1080\/10428190903111922 .","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"532_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ncl.2006.12.002","volume":"25","author":"JY Kwan","year":"2007","unstructured":"Kwan JY. Paraproteinemic neuropathy. Neurol Clin. 2007;25(1):47\u201369. doi: 10.1016\/j.ncl.2006.12.002 .","journal-title":"Neurol Clin"},{"issue":"6 Pt 2","key":"532_CR4","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/j.lpm.2013.02.329","volume":"42","author":"R Rojas-Garcia","year":"2013","unstructured":"Rojas-Garcia R, Gallardo E, Illa I. Paraproteinemic neuropathies. Presse medicale (Paris, France: 1983). 2013;42(6 Pt 2):e225\u201334. doi: 10.1016\/j.lpm.2013.02.329 .","journal-title":"Presse medicale (Paris, France: 1983)"},{"issue":"4","key":"532_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","volume":"62","author":"CN Martyn","year":"1997","unstructured":"Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62(4):310\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"532_CR6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","volume":"31","author":"JJ Kelly Jr","year":"1981","unstructured":"Kelly Jr JJ, Kyle RA, O\u2019Brien PC, Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology. 1981;31(11):1480\u20133.","journal-title":"Neurology"},{"issue":"1","key":"532_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF. Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol. 1982;35(1):63\u20138.","journal-title":"J Clin Pathol"},{"issue":"1","key":"532_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","volume":"30","author":"S Gosselin","year":"1991","unstructured":"Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance. Ann Neurol. 1991;30(1):54\u201361. doi: 10.1002\/ana.410300111 .","journal-title":"Ann Neurol"},{"issue":"13","key":"532_CR9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362\u20139. doi: 10.1056\/NEJMoa054494 .","journal-title":"N Engl J Med"},{"issue":"1","key":"532_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9343(87)90375-5","volume":"82","author":"J Crawford","year":"1987","unstructured":"Crawford J, Eye MK, Cohen HJ. Evaluation of monoclonal gammopathies in the \u201cwell\u201d elderly. Am J Med. 1987;82(1):39\u201345.","journal-title":"Am J Med"},{"issue":"5","key":"532_CR11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749\u201357.","journal-title":"Br J Haematol"},{"issue":"6","key":"532_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1756285612457215","volume":"5","author":"KC Gorson","year":"2012","unstructured":"Gorson KC. An update on the management of chronic inflammatory demyelinating polyneuropathy. Ther Adv Neurol Disord. 2012;5(6):359\u201373. doi: 10.1177\/1756285612457215 .","journal-title":"Ther Adv Neurol Disord"},{"key":"532_CR13","volume-title":"Multiple Myeloma","author":"D Shah","year":"2015","unstructured":"Shah D, Seiter K. Multiple Myeloma. 2015. http:\/\/emedicine.medscape.com\/article\/204369-overview-showall ."},{"key":"532_CR14","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/B978-0-7216-9491-7.50103-4","volume-title":"Peripheral Neuropathy","author":"R Kyle","year":"2005","unstructured":"Kyle R, Dyck PJ. Neuropathy associated with the monoclonal gammopathies. In: Dyck PJ, Thomas PK, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 2255\u201376.","edition":"4"},{"issue":"6","key":"532_CR15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0404.1992.tb06033.x","volume":"85","author":"E Nobile-Orazio","year":"1992","unstructured":"Nobile-Orazio E, Barbieri S, Baldini L, Marmiroli P, Carpo M, Premoselli S, et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies. Acta Neurol Scand. 1992;85(6):383\u201390.","journal-title":"Acta Neurol Scand"},{"key":"532_CR16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1752-1947-4-298","volume":"4","author":"RA Rison","year":"2010","unstructured":"Rison RA, Beydoun SR. Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature. J Med Case Reports. 2010;4:298. doi: 10.1186\/1752-1947-4-298 .","journal-title":"J Med Case Reports"},{"issue":"3","key":"532_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<149::AID-JCA8>3.0.CO;2-9","volume":"14","author":"KC Gorson","year":"1999","unstructured":"Gorson KC. Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS). J Clin Apher. 1999;14(3):149\u201353.","journal-title":"J Clin Apher"},{"issue":"5","key":"532_CR18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1212\/WNL.0b013e3181ccc6b9","volume":"74","author":"JM Niermeijer","year":"2010","unstructured":"Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study. Neurology. 2010;74(5):406\u201312. doi: 10.1212\/WNL.0b013e3181ccc6b9 .","journal-title":"Neurology"},{"key":"532_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","volume":"15","author":"RD Hadden","year":"2010","unstructured":"Hadden RD, Nobile-Orazio E, Sommer C. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on Management of Paraproteinaemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Periph Nerv. 2010;15:185\u201395.","journal-title":"J Periph Nerv"},{"issue":"6","key":"532_CR20","first-page":"889","volume":"19","author":"C Ferri","year":"1992","unstructured":"Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S, et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol. 1992;19(6):889\u201395.","journal-title":"J Rheumatol"},{"issue":"2","key":"532_CR21","first-page":"131","volume":"1","author":"LM Caniatti","year":"1996","unstructured":"Caniatti LM, Tugnoli V, Eleopra R, Tralli G, Bassi R, De Grandis D. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. J Peripher Nerv Syst. 1996;1(2):131\u20138.","journal-title":"J Peripher Nerv Syst"},{"issue":"11","key":"532_CR22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1988.00520350048015","volume":"45","author":"F Garcia-Bragado","year":"1988","unstructured":"Garcia-Bragado F, Fernandez JM, Navarro C, Villar M, Bonaventura I. Peripheral neuropathy in essential mixed cryoglobulinemia. Arch Neurol. 1988;45(11):1210\u20134.","journal-title":"Arch Neurol"},{"issue":"1","key":"532_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/1040-8428(90)90021-J","volume":"10","author":"RA Kyle","year":"1990","unstructured":"Kyle RA, Gertz MA. Systemic amyloidosis. Crit Rev Oncol Hematol. 1990;10(1):49\u201387.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"532_CR24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","volume":"36","author":"MD Benson","year":"2007","unstructured":"Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve. 2007;36(4):411\u201323. doi: 10.1002\/mus.20821 .","journal-title":"Muscle Nerve"},{"issue":"10","key":"532_CR25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/mus.1162","volume":"24","author":"SR Beydoun","year":"2001","unstructured":"Beydoun SR, Rison RA, Commins D. Secondary amyloidosis as a life-ending event in multifocal motor neuropathy. Muscle Nerve. 2001;24(10):1396\u2013402.","journal-title":"Muscle Nerve"},{"issue":"Pt 10","key":"532_CR26","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","volume":"124","author":"HJ Willison","year":"2001","unstructured":"Willison HJ, O\u2019Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain. 2001;124(Pt 10):1968\u201377.","journal-title":"Brain"},{"issue":"4","key":"532_CR27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00415-009-5412-z","volume":"257","author":"E Delmont","year":"2010","unstructured":"Delmont E, Jeandel PY, Hubert AM, Marcq L, Boucraut J, Desnuelle C. Successful treatment with rituximab of one patient with CANOMAD neuropathy. J Neurol. 2010;257(4):655\u20137. doi: 10.1007\/s00415-009-5412-z .","journal-title":"J Neurol"},{"key":"532_CR28","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/B978-0-7216-9491-7.50112-5","volume-title":"Peripheral Neuropathy","author":"A Dispenzieri","year":"2005","unstructured":"Dispenzieri A, Suarez GA, Kyle R. POEMS syndrome. In: Dyck PJ, Thomas P, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Sanders; 2005. p. 2453\u201369.","edition":"4"},{"key":"532_CR29","doi-asserted-by":"crossref","unstructured":"Rison RA. Papilloedema and hypertrichosis: the varied and harried manifestations of POEMS syndrome. BMJ case reports. 2009. doi: 10.1136\/bcr.09.2008.1000 .","DOI":"10.1136\/bcr.09.2008.1000"},{"issue":"6","key":"532_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(94)90350-6","volume":"97","author":"MJ Soubrier","year":"1994","unstructured":"Soubrier MJ, Dubost JJ, Sauvezie BJ. POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. Am J Med. 1994;97(6):543\u201353.","journal-title":"Am J Med"},{"key":"532_CR31","first-page":"Cd006828","volume":"6","author":"S Kuwabara","year":"2012","unstructured":"Kuwabara S, Dispenzieri A, Arimura K, Misawa S, Nakaseko C. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev. 2012;6:Cd006828. doi: 10.1002\/14651858.CD006828.pub3 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"532_CR32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.2007.125930","volume":"79","author":"K Viala","year":"2008","unstructured":"Viala K, Behin A, Maisonobe T, Leger JM, Stojkovic T, Davi F, et al. Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry. 2008;79(7):778\u201382. doi: 10.1136\/jnnp.2007.125930 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"532_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/mus.20163","volume":"31","author":"JJ Kelly","year":"2005","unstructured":"Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve. 2005;31(3):301\u201313. doi: 10.1002\/mus.20163 .","journal-title":"Muscle Nerve"},{"issue":"1","key":"532_CR34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1529-8027.2010.00251.x","volume":"15","author":"K Viala","year":"2010","unstructured":"Viala K, Maisonobe T, Stojkovic T, Koutlidis R, Ayrignac X, Musset L, et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2010;15(1):50\u20136. doi: 10.1111\/j.1529-8027.2010.00251.x .","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"532_CR35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.21206","volume":"39","author":"YA Rajabally","year":"2009","unstructured":"Rajabally YA, Simpson BS, Beri S, Bankart J, Gosalakkal JA. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve. 2009;39(4):432\u20138. doi: 10.1002\/mus.21206 .","journal-title":"Muscle Nerve"},{"issue":"7","key":"532_CR36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00319857","volume":"238","author":"KB Yeung","year":"1991","unstructured":"Yeung KB, Thomas PK, King RH, Waddy H, Will RG, Hughes RA, et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol. 1991;238(7):383\u201391.","journal-title":"J Neurol"},{"issue":"17","key":"532_CR37","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","volume":"118","author":"A D\u2019Souza","year":"2011","unstructured":"D\u2019Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011;118(17):4663\u20135. doi: 10.1182\/blood-2011-06-362392 .","journal-title":"Blood"},{"issue":"6","key":"532_CR38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24(6):1121\u20137. doi: 10.1038\/leu.2010.60 .","journal-title":"Leukemia"},{"key":"532_CR39","volume-title":"Monoclonal Gammopathies of Uncertain Origin","author":"S Fanning","year":"2014","unstructured":"Fanning S, Hussein M. Monoclonal Gammopathies of Uncertain Origin. 2014. Medscape, http:\/\/emedicine.medscape.com\/article\/204297-medication . Accessed September 18, 2015."},{"issue":"4","key":"532_CR40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1750-3639.2001.tb00407.x","volume":"11","author":"A Vital","year":"2001","unstructured":"Vital A. Paraproteinemic neuropathies. Brain Pathol (Zurich, Switzerland). 2001;11(4):399\u2013407.","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"key":"532_CR41","first-page":"Cd002827","volume":"5","author":"MP Lunn","year":"2012","unstructured":"Lunn MP, Nobile-Orazio E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev. 2012;5:Cd002827. doi: 10.1002\/14651858.CD002827.pub3 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"532_CR42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","volume":"40","author":"MC Dalakas","year":"1996","unstructured":"Dalakas MC, Quarles RH, Farrer RG, Dambrosia J, Soueidan S, Stein DP, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol. 1996;40(5):792\u20135. doi: 10.1002\/ana.410400516 .","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"532_CR43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","volume":"123","author":"E Nobile-Orazio","year":"2000","unstructured":"Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain. 2000;123(Pt 4):710\u20137.","journal-title":"Brain"},{"issue":"6","key":"532_CR44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mus.1069","volume":"24","author":"KC Gorson","year":"2001","unstructured":"Gorson KC, Ropper AH, Weinberg DH, Weinstein R. Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy. Muscle Nerve. 2001;24(6):778\u201386.","journal-title":"Muscle Nerve"},{"issue":"10","key":"532_CR45","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-002-0808-z","volume":"249","author":"G Comi","year":"2002","unstructured":"Comi G, Roveri L, Swan A, Willison H, Bojar M, Illa I, et al. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol. 2002;249(10):1370\u20137. doi: 10.1007\/s00415-002-0808-z .","journal-title":"J Neurol"},{"issue":"2","key":"532_CR46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1526-0968.2003.00036.x","volume":"7","author":"L Guillevin","year":"2003","unstructured":"Guillevin L, Pagnoux C. Indications of plasma exchanges for systemic vasculitides. Ther Apher Dial. 2003;7(2):155\u201360.","journal-title":"Ther Apher Dial"},{"key":"532_CR47","first-page":"Cd005376","volume":"3","author":"AC Stork","year":"2015","unstructured":"Stork AC, Lunn MP, Nobile-Orazio E, Notermans NC. Treatment for IgG and IgA paraproteinaemic neuropathy. Cochrane Database Syst Rev. 2015;3:Cd005376. doi: 10.1002\/14651858.CD005376.pub3 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"532_CR48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1086-5802(16)31332-8","volume":"41","author":"JE Shepherd","year":"2001","unstructured":"Shepherd JE, Grabenstein JD. Immunizations for high-risk populations. J Am Pharm Assoc. 2001;41(6):839\u201349. quiz 923-835.","journal-title":"J Am Pharm Assoc"},{"key":"532_CR49","unstructured":"Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence (1993). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control 42 (Rr-4):1-18"},{"issue":"3","key":"532_CR50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.21577","volume":"65","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, et al. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol. 2009;65(3):286\u201393. doi: 10.1002\/ana.21577 .","journal-title":"Ann Neurol"},{"issue":"24","key":"532_CR51","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","volume":"80","author":"JM Leger","year":"2013","unstructured":"Leger JM, Viala K, Nicolas G, Creange A, Vallat JM, Pouget J, et al. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy. Neurology. 2013;80(24):2217\u201325. doi: 10.1212\/WNL.0b013e318296e92b .","journal-title":"Neurology"},{"issue":"10","key":"532_CR52","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/annonc\/mdh403","volume":"15","author":"SP Treon","year":"2004","unstructured":"Treon SP, Branagan AR, Hunter Z, Santos D, Tournhilac O, Anderson KC. Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom\u2019s macroglobulinemia. Ann Oncol. 2004;15(10):1481\u20133. doi: 10.1093\/annonc\/mdh403 .","journal-title":"Ann Oncol"},{"issue":"2","key":"532_CR53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1756285609356135","volume":"3","author":"ML Kosmidis","year":"2010","unstructured":"Kosmidis ML, Dalakas MC. Practical considerations on the use of rituximab in autoimmune neurological disorders. Ther Adv Neurol Disord. 2010;3(2):93\u2013105. doi: 10.1177\/1756285609356135 .","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"532_CR54","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2005.04.6474","volume":"24","author":"V Noronha","year":"2006","unstructured":"Noronha V, Fynan TM, Duffy T. Flare in neuropathy following rituximab therapy for Waldenstrom\u2019s macroglobulinemia. J Clin Oncol. 2006;24(1), e3. doi: 10.1200\/jco.2005.04.6474 .","journal-title":"J Clin Oncol"},{"issue":"5","key":"532_CR55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.66.5.575","volume":"66","author":"HC Wilson","year":"1999","unstructured":"Wilson HC, Lunn MP, Schey S, Hughes RA. Successful treatment of IgM paraproteinaemic neuropathy with fludarabine. J Neurol Neurosurg Psychiatry. 1999;66(5):575\u201380.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"532_CR56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1529-8027.2011.00343.x","volume":"16","author":"B Gruson","year":"2011","unstructured":"Gruson B, Ghomari K, Beaumont M, Garidi R, Just A, Merle P, et al. Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy. J Peripher Nerv Syst. 2011;16(3):180\u20135. doi: 10.1111\/j.1529-8027.2011.00343.x .","journal-title":"J Peripher Nerv Syst"},{"key":"532_CR57","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/B978-0-7216-9491-7.50111-3","volume-title":"Peripheral Neuropathy","author":"R Kyle","year":"2005","unstructured":"Kyle R, Kelly CM, Dyck PJ. Amyloidosis and Neuropathy. In: Dyck PJ, Thomas P, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 2427\u201351.","edition":"4"},{"issue":"24","key":"532_CR58","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","volume":"117","author":"J Li","year":"2011","unstructured":"Li J, Zhang W, Jiao L, Duan MH, Guan HZ, Zhu WG, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood. 2011;117(24):6445\u20139. doi: 10.1182\/blood-2010-12-328112 .","journal-title":"Blood"},{"key":"532_CR59","volume-title":"Treatment of Painful Diabetic Neuropathy","author":"AA Neurology","year":"2011","unstructured":"Neurology AA. Treatment of Painful Diabetic Neuropathy. 2011. https:\/\/www.aan.com\/Guidelines\/home\/GetGuidelineContent\/480 . Accessed September 18, 2015."},{"issue":"3","key":"532_CR60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.0001-5172.2004.0325.x","volume":"48","author":"KC Carlsson","year":"2004","unstructured":"Carlsson KC, Hoem NO, Moberg ER, Mathisen LC. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand. 2004;48(3):328\u201336. doi: 10.1111\/j.0001-5172.2004.0325.x .","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"532_CR61","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4065\/81.7.880","volume":"81","author":"DH Vesole","year":"2006","unstructured":"Vesole DH, Perez WS, Akasheh M, Boudreau C, Reece DE, Bredeson CN. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study. Mayo Clin Proc. 2006;81(7):880\u20138. doi: 10.4065\/81.7.880 .","journal-title":"Mayo Clin Proc"},{"issue":"21","key":"532_CR62","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000323811.42080.a4","volume":"71","author":"S Kuwabara","year":"2008","unstructured":"Kuwabara S, Misawa S, Kanai K, Suzuki Y, Kikkawa Y, Sawai S, et al. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology. 2008;71(21):1691\u20135. doi: 10.1212\/01.wnl.0000323811.42080.a4 .","journal-title":"Neurology"},{"issue":"8","key":"532_CR63","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF01312569","volume":"28","author":"DJ Costigan","year":"1983","unstructured":"Costigan DJ, Clouse RE. Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig Dis Sci. 1983;28(8):763\u20135.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"532_CR64","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0210-5705(02)70274-4","volume":"25","author":"JM Lopez-Cepero Andrada","year":"2002","unstructured":"Lopez-Cepero Andrada JM, Jimenez Arjona J, Amaya Vidal A, Rubio Garrido J, Navas Relinque C, Soria de la Cruz MJ, et al. Pseudoachalasia and secondary amyloidosis in a patient with rheumatoid arthritis. Gastroenterol Hepatol. 2002;25(6):398\u2013400.","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"532_CR65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1468-1331.2006.01632.x","volume":"14","author":"S Schroder","year":"2007","unstructured":"Schroder S, Liepert J, Remppis A, Greten JH. Acupuncture treatment improves nerve conduction in peripheral neuropathy. Eur J Neurol. 2007;14(3):276\u201381. doi: 10.1111\/j.1468-1331.2006.01632.x .","journal-title":"Eur J Neurol"},{"issue":"2","key":"532_CR66","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood-2007-08-108357","volume":"111","author":"A Dispenzieri","year":"2008","unstructured":"Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, et al. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008;111(2):785\u20139. doi: 10.1182\/blood-2007-08-1 .","journal-title":"Blood"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0532-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:58:14Z","timestamp":1718326694000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2377\/16\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["532"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0532-4","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]},"article-number":"13"}}